seekingalpha.com
/3 weeks ago
Latest updates for Celg.rt
Fresh curated links around CELG.RT are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Celcuity plans late Q3 2026 REVTORPYK shipments and targets sNDA submission in Q3 2026
- Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts
- Fibra Danhos (GRFFF) Q2 2026 Earnings Call Transcript
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts
seekingalpha.com
/1 month ago
Castellum, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
Gentera, S.A.B. de C.V. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript
seekingalpha.com
/3 days ago
Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts
investing.com
/1 month ago
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
seekingalpha.com
/3 weeks ago
Liquidia: YUTREPIA's Launch Opens Upside If Growth Remains And Margins Follow
seekingalpha.com
/1 month ago
Grupo Rotoplas S.A.B. de C.V. (GRPRF) Q2 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
Metrovacesa S.A. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/4 days ago
AT&T Preferred Cumulative Shares Series A And C Seeking A Bid
biopharmadive.com
/1 month ago
Celcuity gains FDA approval for closely-watched breast cancer drug
Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.
seekingalpha.com
/3 weeks ago
Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M
seekingalpha.com
/1 month ago
Multiplan Empreendimentos Imobiliários S.A. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/4 weeks ago
Telecom Argentina S.A. (TEO) Q2 2026 Earnings Call Prepared Remarks Transcript
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Celg.rt
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source
investing.com
Recent coverage from public sources
Public source